SCHEMBL6202905

SCHEMBL6202905

O=C1[N]c2cc(Nc3ccccc3)c(Cc3cccnc3)cc2N1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.41
PLA2G7 Q13093 5/20 0.39
FLT1 P17948 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MPO P05164 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
GSK3B P49841 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BUB1 O43683 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203291 0.90 EGFR (0.39) SMN1; SMN2MEN1KMT2ALMNAMAPT
SCHEMBL6205452 0.83 EGFR (0.36) SMN1; SMN2MPOGSK3BMEN1KMT2A
SCHEMBL6204330 0.82 CNR1 (0.39) FLT1SMN1; SMN2L3MBTL1GSK3BMEN1
SCHEMBL6202957 0.82 ALDH1A1 (0.35) SMN1; SMN2L3MBTL1GSK3BMEN1KMT2A
SCHEMBL6203101 0.82 NPC1 (0.38) SMN1; SMN2L3MBTL1GSK3BMEN1KMT2A
SCHEMBL6205611 0.82 MEN1 (0.38) SMN1; SMN2MEN1KMT2ALMNAMAPT
SCHEMBL6205378 0.80 KMT2A (0.40) SMN1; SMN2GSK3BMEN1KMT2ALMNA
SCHEMBL6204133 0.80 FPR1 (0.43) MEN1KMT2ALMNA
SCHEMBL6202823 0.80 EGFR (0.42) SMN1; SMN2L3MBTL1GSK3BMEN1KMT2A
SCHEMBL6204891 0.80 MAPT (0.38) FLT1SMN1; SMN2L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539708-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2005-06-15 EP disclosed
WO-2004024699-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-03-25 WO disclosed